Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 17, Number 7—July 2011

Research

Hansen Disease among Micronesian and Marshallese Persons Living in the United States

Patricia Woodall, David ScollardComments to Author , and Latha Rajan
Author affiliations: Author affiliations: Tulane University, New Orleans, Lousiana, USA (P. Woodall, L. Rajan); National Hansen’s Disease Program, Baton Rouge, Louisiana, USA (D. Scollard)

Main Article

Table 1

Hansen disease in residents of Micronesian and Marshallese origin, United States*

Population group
No. (%) patients
Median time from US entry to report, y (range)
MDT,†
no. (%)
Complications, no. cases
Total
MB
F
Age <15 y
ENL
RR
Hand/foot neuropathy
Eye
Other
Any
(%)‡
Hawaii-residing Micronesians, 2000–2009§ 29 22 (76) 5 (17) 3 (10) 1.5 (0–13) NA NA NA NA NA NA NA
Hawaii-residing Marshallese, 2000–2009§ 43 31 (72) 17 (39) 1 (2) 1 (0–14) NA NA NA NA NA NA NA
US Mainland Micronesians, 1990–2009 55 42 (76) 10 (18) 6 (10) 3 (0–10) 10 (42) 15 3 8 6 25
(77)
US Mainland Marshallese, 1990–2009 33 25 (76) 11 (33) 3 (10) 2 (0–12) 7 (32) 6 3 5 1 1# 12 (75)
Arkansas-residing Marshallese, 1990–2009 17 15 (88) 5 (30) 0 (0) 2 (0–5) 3 (20) 4 2 2 0 0 12
(70)

*Data from National Hansen’s Disease Program surveillance and clinical records, January 1990–October 2009. MB, multibacillary; MDT, multidrug therapy; ENL, erythema nodosum leprosum; RR, reversal reaction; NA, data not available.
†MDT completed, excluding patients currently under active treatment.
‡Patients for whom clinical data were available.
§Pre-2000 data were not reported to National Hansen’s Disease Program.
¶1 renal, 1 testicular, 1 palatal.
#1 renal.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO